New Drugs for Treating Dyslipidemia: Beyond Statins
Statins have been shown to be very effective and safe in numerous randomized clinical trials, and became the implacable first-line treatment against atherogenic dyslipidemia. However, even with optimal statin treatment, 60% to 80% of residual cardiovascular risk still exists. The patients with famil...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Korean Diabetes Association
2015
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411552/ |